Intuitive Surgical Inc (ISRG)

Industry Medical Instruments & Supplies

This stock can be held in an Investment ISA and an Investment Account
Sell

$545.00

Buy

$555.00

arrow-down$-3.41 (-0.61%)

Intuitive Surgical Inc designs, manufactures, markets da Vinci Surgical Systems, and related instruments. The da Vinci surgery, combines the benefits of minimally invasive surgery for patients with the ease of use, precision and dexterity of open surgery.
Prices updated at 31 May 2025, 00:42 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Sector
Healthcare
Industry
Medical Instruments & Supplies
Chairman
Dr. Craig H. Barratt,PhD
CEO
Dr. Gary S. Guthart,PhD
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
15,638
Head office
1020 Kifer Road
Sunnyvale
United States
94086-5304
mobile
+1 408 523-2100
letter
investor.relations@intusurg.com

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Dr. Gary S. Guthart,PhD
Director and Chief Executive Officer
1.01m--18.20m-
Mr. Jamie E. Samath
Executive Vice President, Chief Financial Officer and Head, Business Technology
0.60m--7.03m-
Mr. David J. Rosa
President and Director
0.75m--13.76m-
Mr. Henry L. Charlton
Executive Vice President, Chief Commercial and Marketing Officer
0.60m--6.47m-
Ms. Amal M. Johnson
Independent Director
0.09m--0.37m-
Dr. Craig H. Barratt,PhD
Chairman of the Board
0.08m--0.47m-
Ms. Jami Dover Nachtsheim
Independent Director
0.09m--0.36m-
Mr. Lewis Chew
Independent Director
0.06m--0.34m-
Mr. Keith R. Leonard, Jr
Independent Director
0.08m--0.36m-
Mr. Joseph C. Beery
Independent Director
0.08m--0.35m-
Mr. Gary H. Loeb
Executive Vice President, Chief Legal Officerand Chief Compliance Officer
-----
Dr. Myriam J. Curet, F.A.C.S.,M.D.
Executive Vice President and Chief Medical Officer
-----
Ms. Sreelakshmi Kolli
Independent Director
0.08m--0.35m-
Mr. Robert DeSantis
Executive Vice President and Chief Strategy and Corporate Operations Officer
-----
Dr. Amy L. Ladd, M.D.
Independent Director
0.08m--0.36m-
Dr. Monica P. Reed, M.D.
Independent Director
0.08m--0.36m-
Mr. Fredrik C. Widman
Principal Accounting Officer, Vice President and Corporate Controller
-----
Mr. Mark P. Brosius
Senior Vice President and Chief Manufacturing and Supply Chain Officer
-----
Dr. Brian E. Miller, PhD
Executive Vice President and Chief Digital Officer
0.55m--6.20m-

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
Vanguard Group Inc32,665,5310.29254533351.4073430 Apr 20259.11
BlackRock Inc31,449,5610.32716722300.23019830 Apr 20258.77
State Street Corp15,369,3320.31368639070.41754530 Apr 20254.29
T. Rowe Price Associates, Inc.13,783,2430.84109-686369-4.7435230 Apr 20253.85
Fidelity Management & Research Company LLC12,173,20120.13189-648108-30 Apr 20253.40

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
10 Dec 2024-Mr. Jamie E. Samath229.3930,9688,892--
10 Dec 2024-Mr. Jamie E. Samath540.1572,9218,757--
10 Dec 2024-Mr. Jamie E. Samath--3,501--
10 Dec 2024-Mr. Jamie E. Samath540.1572,9218,757--
10 Dec 2024-Mr. Jamie E. Samath--3,501--
10 Dec 2024-Mr. Jamie E. Samath304.6741,1308,892--
29 Nov 2024-Mr. Jamie E. Samath208.9019,6378,851--
29 Nov 2024-Mr. Jamie E. Samath290.3327,2918,851--
29 Nov 2024-Mr. Jamie E. Samath--1,410--
29 Nov 2024-Mr. Jamie E. Samath--1,410--
29 Nov 2024-Mr. Jamie E. Samath539.0050,6668,757--
29 Nov 2024-Mr. Jamie E. Samath539.0050,6668,757--
29 Nov 2024-Mr. Robert DeSantis208.9039,2735,694--
29 Nov 2024-Mr. Robert DeSantis290.3354,5825,694--
29 Nov 2024-Mr. Robert DeSantis--2,820--
29 Nov 2024-Mr. Robert DeSantis--2,820--
29 Nov 2024-Mr. Robert DeSantis539.00101,3325,506--
29 Nov 2024-Mr. Robert DeSantis539.00101,3325,506--
26 Nov 2024-Mr. Jamie E. Samath542.0629,2718,757--
26 Nov 2024-Mr. Jamie E. Samath347.4218,7618,811--
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.